Yaqing M. Li

Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.

Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.

Journal: Oncotarget
Published: November 07, 2025

Clinical features and prognostic factors of intravascular large B-cell lymphoma: a cohort study of 20 patients from 2018 to 2024.

Clinical features and prognostic factors of intravascular large B-cell lymphoma: a cohort study of 20 patients from 2018 to 2024.

Journal: The oncologist
Published: January 16, 2025

USP19 exerts a tumor-promoting role in diffuse large B cell lymphoma through stabilizing PARK7.

USP19 exerts a tumor-promoting role in diffuse large B cell lymphoma through stabilizing PARK7.

Journal: The FEBS journal
Published: November 02, 2023

Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China

Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 17, 2020

MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.

MKL1-induced lncRNA SNHG18 drives the growth and metastasis of non-small cell lung cancer via the miR-211-5p/BRD4 axis.

Journal: Cell death & disease
Published: September 04, 2020

Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet.

Generation of an oxoglutarate dehydrogenase knockout rat model and the effect of a high-fat diet.

Journal: RSC advances
Published: January 10, 2018

MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.

MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: August 10, 2017

Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.

Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.

Journal: Oncotarget
Published: November 09, 2016

Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.

Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.

Journal: Oncotarget
Published: September 30, 2016

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.

Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells.

Journal: Scientific reports
Published: September 07, 2016

Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.

Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.

Journal: Oncotarget
Published: September 02, 2016

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.

Journal: BMC cancer
Published: June 23, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026